Ibrutinib and Venetoclax for First-Line Treatment of CLL von Jain, Nitin, Keating, Michael, Thompson, Philip, Ferrajoli, Alessandra, Burger, Jan, Borthakur, Gautam, Takahashi, Koichi, Estrov, Zeev, Fowler, Nathan, Kadia, Tapan, Konopleva, Marina, Alvarado, Yesid, Yilmaz, Musa, DiNardo, Courtney, Bose, Prithviraj, Ohanian, Maro, Pemmaraju, Naveen, Jabbour, Elias, Sasaki, Koji, Kanagal-Shamanna, Rashmi, Patel, Keyur, Jorgensen, Jeffrey, Garg, Naveen, Wang, Xuemei, Sondermann, Katrina, Cruz, Nichole, Wei, Chongjuan, Ayala, Ana, Plunkett, William, Kantarjian, Hagop, Gandhi, Varsha, Wierda, William

Volltext

Therapeutic Advances in Immunotherapies for Hematological Malignancies von Nogami, Ayako, Sasaki, Koji

Volltext

De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017 von Sasaki, Koji, Ravandi, Farhad, Kadia, Tapan M., DiNardo, Courtney D., Short, Nicholas J., Borthakur, Gautam, Jabbour, Elias, Kantarjian, Hagop M.

Volltext

Current status and novel strategy of CML von Morita, Kiyomi, Sasaki, Koji

Volltext

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs von Réa, Delphine, Mauro, Michael J., Boquimpani, Carla, Minami, Yosuke, Lomaia, Elza, Voloshin, Sergey, Turkina, Anna, Kim, Dong-Wook, Apperley, Jane F., Abdo, Andre, Fogliatto, Laura Maria, Kim, Dennis Dong Hwan, le Coutre, Philipp, Saussele, Susanne, Annunziata, Mario, Hughes, Timothy P., Chaudhri, Naeem, Sasaki, Koji, Chee, Lynette, García-Gutiérrez, Valentin, Cortes, Jorge E., Aimone, Paola, Allepuz, Alex, Quenet, Sara, Bédoucha, Véronique, Hochhaus, Andreas

Volltext

Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia von Yoshifuji, Kota, Sasaki, Koji

Volltext

Acute lymphoblastic leukemia: A population‐based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980–2017 von Sasaki, Koji, Jabbour, Elias, Short, Nicholas J., Jain, Nitin, Ravandi, Farhad, Pui, Ching‐Hon, Kantarjian, Hagop

Volltext

Long-term surveillance provides real-world evidences of safety and effectiveness in intravitreal aflibercept treatment for age-related macular degeneration von Ozawa, Yoko, Ohgami, Kazuhiro, Sasaki, Koji, Hirano, Kazufumi, Sunaya, Toshiyuki

Volltext

High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance von Yang, Hui, Garcia-Manero, Guillermo, Sasaki, Koji, Montalban-Bravo, Guillermo, Tang, Zhenya, Wei, Yue, Kadia, Tapan, Chien, Kelly, Rush, Diana, Nguyen, Ha, Kalia, Awdesh, Nimmakayalu, Manjunath, Bueso-Ramos, Carlos, Kantarjian, Hagop, Medeiros, L. Jeffrey, Luthra, Rajyalakshmi, Kanagal-Shamanna, Rashmi

Volltext

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c) von Fiskus, Warren, Boettcher, Steffen, Daver, Naval, Mill, Christopher P., Sasaki, Koji, Birdwell, Christine E., Davis, John A., Takahashi, Koichi, Kadia, Tapan M., DiNardo, Courtney D., Jin, Qi, Qi, Yuan, Su, Xiaoping, McGeehan, Gerard M., Khoury, Joseph D., Ebert, Benjamin L., Bhalla, Kapil N.

Volltext

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia von Morita, Kiyomi, Kantarjian, Hagop M, Wang, Feng, Yan, Yuanqing, Bueso-Ramos, Carlos, Sasaki, Koji, Issa, Ghayas C, Wang, Sa, Jorgensen, Jeffrey, Song, Xingzhi, Zhang, Jianhua, Tippen, Samantha, Thornton, Rebecca, Coyle, Marcus, Little, Latasha, Gumbs, Curtis, Pemmaraju, Naveen, Daver, Naval, DiNardo, Courtney D, Konopleva, Marina, Andreeff, Michael, Ravandi, Farhad, Cortes, Jorge E, Kadia, Tapan, Jabbour, Elias, Garcia-Manero, Guillermo, Patel, Keyur P, Futreal, P Andrew, Takahashi, Koichi

Volltext

Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN von Jabbour, Elias, Short, Nicholas J., Montalban-Bravo, Guillermo, Huang, Xuelin, Bueso-Ramos, Carlos, Qiao, Wei, Yang, Hui, Zhao, Chong, Kadia, Tapan, Borthakur, Gautam, Pemmaraju, Naveen, Sasaki, Koji, Estrov, Zeev, Cortes, Jorge, Ravandi, Farhad, Alvarado, Yesid, Komrokji, Rami, Sekeres, Mikkael A., Steensma, David P., DeZern, Amy, Roboz, Gail, Kantarjian, Hagop, Garcia-Manero, Guillermo

Volltext

Management of chronic myeloid leukemia in 2023 – common ground and common sense von Senapati, Jayastu, Sasaki, Koji, Issa, Ghayas C., Lipton, Jeffrey H., Radich, Jerald P., Jabbour, Elias, Kantarjian, Hagop M.

Volltext

Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib von Sasaki, Yuya, Kantarjian, Hagop M., Short, Nicholas J., Wang, Feng, Furudate, Ken, Uryu, Hidetaka, Garris, Rebecca, Jain, Nitin, Sasaki, Koji, Ravandi, Farhad, Konopleva, Marina, Garcia-Manero, Guillermo, Little, Latasha, Gumbs, Curtis, Zhao, Li, Futreal, P. Andrew, Takahashi, Koichi, Jabbour, Elias

Volltext

Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes von Montalban-Bravo, Guillermo, Class, Caleb A., Ganan-Gomez, Irene, Kanagal-Shamanna, Rashmi, Sasaki, Koji, Richard-Carpentier, Guillaume, Naqvi, Kiran, Wei, Yue, Yang, Hui, Soltysiak, Kelly A., Chien, Kelly, Bueso-Ramos, Carlos, Do, Kim-Anh, Kantarjian, Hagop, Garcia-Manero, Guillermo

Volltext

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study von Jabbour, Elias, Dr, Kantarjian, Hagop, Prof, Ravandi, Farhad, Prof, Thomas, Deborah, Prof, Huang, Xuelin, Prof, Faderl, Stefan, Prof, Pemmaraju, Naveen, Prof, Daver, Naval, MD, Garcia-Manero, Guillermo, Prof, Sasaki, Koji, MD, Cortes, Jorge, Prof, Garris, Rebecca, Yin, C Cameron, MD, Khoury, Joseph D, MD, Jorgensen, Jeffrey, Prof, Estrov, Zeev, Prof, Bohannan, Zachary, MA, Konopleva, Marina, MD, Kadia, Tapan, MD, Jain, Nitin, MD, DiNardo, Courtney, MD, Wierda, William, Prof, Jeanis, Vicky, RN, O'Brien, Susan, Prof

Volltext

Mid-term Outcomes and Predictors of Transarterial Embolization for Type II Endoleak After Endovascular Abdominal Aortic Aneurysm Repair von Horinouchi, Hiroki, Okada, Takuya, Yamaguchi, Masato, Maruyama, Koji, Sasaki, Koji, Gentsu, Tomoyuki, Ueshima, Eisuke, Sofue, Keitaro, Kawasaki, Ryota, Nomura, Yoshikatsu, Omura, Atsushi, Okada, Kenji, Sugimoto, Koji, Murakami, Takamichi

Volltext

Early mortality after chemotherapy as a quality indicator—the leukemia perspective von Kantarjian, Hagop, Welch, Mary Alma, Sasaki, Koji

Volltext

Hypomethylating agent and venetoclax with FLT3 inhibitor “triplet” therapy in older/unfit patients with FLT3 mutated AML von Yilmaz, Musa, Kantarjian, Hagop, Short, Nicholas J., Reville, Patrick, Konopleva, Marina, Kadia, Tapan, DiNardo, Courtney, Borthakur, Gautam, Pemmaraju, Naveen, Maiti, Abhishek, Jabbour, Elias, Jain, Nitin, Issa, Ghayas, Takahashi, Koichi, Sasaki, Koji, Ohanian, Maro, Pierce, Sherry, Tang, Guillin, Loghavi, Sanam, Patel, Keyur, Wang, Sa A., Garcia-Manero, Guillermo, Andreeff, Michael, Ravandi, Farhad, Daver, Naval

Volltext

Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regi... von Ohji, Masahito, Okada, Annabelle A., Sasaki, Koji, Moon, SungChul Charles, Machewitz, Tobias, Takahashi, Kanji

Volltext